A small plastic bottle, a pump that squeaks slightly with use, a minty scent recognizable from a thousand: this decongestant spray has accompanied generations of stuffed noses. It sits in almost every bathroom in France, wedged between bandages and thermometers, ready to be used at the first sign of a cold. Yet this banal reflex is today attracting particular scrutiny from health authorities. Because behind this automatic gesture lies a mechanism that few households truly understand, and which could well challenge decades of deeply ingrained habits.
- Prolonged use of vasoconstrictor-based decongestant sprays triggers a rebound effect that worsens nasal congestion.
- The ANSM has confirmed rare but serious cardiovascular and neurological adverse effects, and now requires a prescription for all pseudoephedrine-based medications, including oral forms since late 2024.
- Facing a cold that typically heals on its own within one to two weeks, the ANSM recommends prioritizing milder alternatives such as saline nasal rinses, steam inhalation, or rest.
- The reflex gesture that hides a pharmacological trap
- When the remedy becomes the problem: the rebound effect unveiled
- What the health authorities’ new position really changes
The reflex gesture that masks a pharmacological trap
From the first sneezes, the hand reaches for the spray, almost without thinking. This gesture, passed down through generations, has become so commonplace that it has turned into a family reflex. For a long time, these vasoconstrictor-based products, including the famous pseudoephedrine, benefited from a reassuring image, reinforced by advertising campaigns promising a nose cleared in a few minutes. The result: few people take the time to read the instructions, even fewer respect the recommended duration of use. This commercial success eventually masked a more nuanced reality, that of a medication effective in the short term, but potentially risky if used without discernment.
When the remedy becomes the problem: the rebound effect unveiled
That is where the problem lies. The ANSM, the agency charged with monitoring the safety of medicines in France, has sharpened its position based on a simple yet concerning finding: after a few days of use, the spray no longer relieves congestion, it sustains it. The nasal blood vessels, continually stimulated, end up dilating once the treatment stops, causing an obstruction that is even more stubborn than at the start. This is what is called the rebound effect, a vicious circle that pushes people to restart the product again and again, without truly curing. But the risk is not limited to this discomfort. The agency also confirmed more serious, though rare, adverse effects, including cardiovascular problems and neurological syndromes such as posterior reversible encephalopathy syndrome, which can affect individuals with no notable medical history. A cold, however, usually heals spontaneously in about seven to ten days, which questions the prudence of taking such risks for a condition so benign.
What the health authorities’ new position really changes
In light of these findings, the ANSM has significantly tightened the regulation of these treatments. Since late 2024, all oral pseudoephedrine-based medicines are no longer dispensed without a prescription, a tightening that aligns with the nasal forms, which have already required a prescription for several years due to their neurological and cardiovascular effects. The public advertising ban, implemented earlier, had not sufficed to curb misuse: without medical guidance, treatment durations and contraindications were too often ignored. A recently published survey confirmed these concerns, revealing that fewer than 15% of over-the-counter medicines analyzed are both effective and truly safe over time. Concretely, this means that medical advice is now mandatory before any use, and milder alternatives, such as saline nasal irrigation, warm steam, or simply rest, must reclaim their place as the first reflex for a congested nose.
This familiar little bottle thus reveals a reality more complex than it seems: immediate relief that can become a trap if its limits are not understood. At the start of autumn, as the first seasonal colds begin to show up, it may be time to rethink this reflex inherited from previous generations and to favor patience over express solutions.
